Specific type of immune regulatory cells could be used as potential clinical biomarkers to diagnose certain autoimmune diseases

These cells are usually found in lymphoid tissues where they regulate antibody production. It was a surprise to find an increase of these type of cells in patients with excessive antibody production. In fact, the results now published in Science Immunology, were the opposite of what the team was expecting.

To understand the reason behind such unexpected results the researchers studied different biological samples. For instance, comparing T_fr cells in the blood and in the tissues where antibodies are produced (tonsils obtained from children subjected to tonsillectomies), provided evidence that blood T_fr cells are immature, not able to fully suppress antibody production. Such immaturity was confirmed by studying blood samples from other patients with genetic defects. Furthermore, exposure of healthy volunteers to flu vaccine led to an increase in blood T_fr cells, in line with their generation during immune responses with antibody production.

Blood circulating T_fr cells are distinguished from other circulating lymphocytes by two molecular markers, CXCR5 and FOXP3, the first of which endows these cells with the ability to migrate into specific zones of lymph nodes where they may complete maturation and regulate antibody production.

The team is now trying to understand what happens to these cells in other autoimmune diseases to evaluate their potential not only for diagnostic but also to identify which patients may benefit with medicines that interfere with the production of harmful antibodies.